Airway persistence by the emerging multi-azole-resistant Rasamsonia argillacea complex in cystic fibrosis.

导出原文传递

翻译打印收藏纠错

第一作者： Alireza,Abdolrasouli

第一单位： Fungal Pathogens Laboratory, National Heart and Lung Institute, Imperial College London, London, UK.

作者： Alireza,Abdolrasouli ^[1] ; Amelia C,Bercusson ^[1] ; Johanna L,Rhodes ^[2] ; Ferry,Hagen ^[3] ; Jochem B,Buil ^[4] ; Alison Y Y,Tang ^[5] ; Leonard L,de Boer ^[3] ; Anand,Shah ^[4] ; Andrew J,Milburn ^[1] ; J Stuart,Elborn ^[1] ; Andrew L,Jones ^[6] ; Jacques F,Meis ^[6] ; Matthew C,Fisher ^[6] ; Silke,Schelenz ^[6] ; Nicholas J,Simmonds ^[3] ; Darius,Armstrong-James ^[4]

作者单位： Fungal Pathogens Laboratory, National Heart and Lung Institute, Imperial College London, London, UK. ^[1] Department of Infectious Diseases Epidemiology, Imperial College School of Public Health, London, UK. ^[2] Department of Medical Microbiology and Infectious Diseases, Canisius-Wilhelmina Hospital (CWZ), Nijmegen, The Netherlands. ^[3] Centre of Expertise in Mycology Radboud UMC/CWZ and ECMM Excellence Center for Medical Mycology, Nijmegen, The Netherlands. ^[4] Department of Medical Mycology, Westerdijk Fungal Biodiversity Institute, Utrecht, The Netherlands. ^[5] Adult Cystic Fibrosis Centre, Royal Brompton and Harefield NHS Foundation Trust, London, UK. ^[6] Department of Microbiology, Royal Brompton and Harefield NHS Foundation Trust, London, UK. ^[7]

关键词 Rasamsonia argillacea species complex antifungal susceptibility testing cystic fibrosis genotyping outcome